Direvo Biotech AG and Pfizer Inc. (PFE) Collaborate on Therapeutic Proteases  
11/13/2007 1:23:20 PM

DIREVO Biotech AG today announced the signing of a collaboration agreement with Pfizer, Inc., New York, to develop therapeutic proteases for different targets as potential treatments for various diseases. Direvo will apply its protein-engineering capabilities to create novel proteases with engineered specificity for these targets.